Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: Therapeutic implications

Anti-Cancer Drug Design

Volumn 15, Issue 1, 2000, Pages 67-72

  Girnita, Leonard ^a   Wang, Min ^a   Xie, Yuntao ^a   Nilsson, Gunnar ^a   Dricu, Anica ^a   Wejde, Johan ^a   Larsson, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell death; Ewing's sarcoma cells; IGF 1R; Lovastatin; N linked glycosylation; Tunicamycin

Indexed keywords

MEVINOLIN; SOMATOMEDIN C RECEPTOR; TUNICAMYCIN;

ARTICLE; CELL SURFACE; DNA SYNTHESIS; GLYCOSYLATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SARCOMA CELL;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; DOWN-REGULATION; GLYCOSYLATION; HUMANS; LOVASTATIN; RECEPTOR, IGF TYPE 1; SARCOMA, EWING'S; TUMOR CELLS, CULTURED; TUNICAMYCIN;

EID: 0034120198     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baserga R. (1995) The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Research, 55, 249.
2. Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Analytical Biochemistry, 72, 248.
3. Carlberg M., Drieu A., Biegen H., Wang M., Hjertman M., Zickert P., Höög A., Larsson O. (1996) Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Journal of Biological Chemistry, 271, 17453.
4. Conover A., Hintz R.I., Rosenfeld R.G. (1989) Direct evidence that insulin receptor mediates a mitogenic response in cultured human fibroblast. Hormone Metabolism Research, 21, 59.
5. Dricu A., Wang M., Hjertman M., Malec M., Biegen H., Wejde J., Carlberg M., Larsson O. (1997a) Mevalonate-regulated cell growth in human tumor cells: role of glycosylation of the IGF-1 receptor, prenylation of Ras and expression of c-Myc. Glycobiology, 7, 625.
6. Dricu A., Carlberg M., Wang M., Larsson O. (1997b) Inhibition of N-linked glycosylation using tunicamycin causes cell death in human malignant cells: role of down-regulation of the insulin-like growth factor-1 receptor in induction of apoptosis. Cancer Research, 57, 543.
7. Evan G., Wyllie A.H., Gilberts C.S., Littlewood T.D., Land H., Brooks M., Pen L.Z., Hancock D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119.
8. Gammeltoft S. (1990) Peptide hormone action. A practical approach. In Peptide Receptors. Ridel K., Hutton J.C. (eds), p. 1. Oxford University Press: Oxford.
9. Harrington E.A., Bennet M.R., Fanidi A., Evan G.I. (1995) C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO Journal, 13, 3286.
10. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680.
11. Liu Q., Ning W., Danzer R., Freund G.G., Kelley K.W. (1998) Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-1. Journal of Immunology, 160, 1393.
12. Lowe W.L. Jr (1991) Biological actions of the insulin-like growth factors. In: Insulin-like Growth Factors: Molecular and Cellular Aspects. ReRoith, D (ed.), p. 49. CRC Press: Boca Raton, FL.
13. McKeon C., Thiele C.J., Ross R.A., Kwan M., Triche TJ. Miser E.S., Israel M.A. (1988) Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Research, 48, 4307.
14. Massague J., Czech M.P. (1992) The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. Journal of Biological Chemistry, 257, 538.
15. Prager D., Li H.L., Asa S., Melmed S. (1994) Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor mutant. Proceedings of National Academy of Science, USA, 91, 2181.
16. Resnicoff M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga R., Rubin R. (1994) Rat glioblastoma cells expressing an antisense RNA to insulin-like growth factor-1 (IGF-1R) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Research, 54, 2218.
17. Resnicoff M., Abrahams D., Yutana Wiboonchai W., Rotman H., Kajstura J., Rubin R., Zoltick P., Baserga R. (1995) The insulin-like growth factor-1 receptor protect human cells from apoptosis in vivo. Cancer Research, 55, 463.
18. Rubin R., Baserga R. (1995) Insulin-like growth factor-1 receptor. Its role in cell proliferation, apoptosis and tumorigenicity. Laboratory Investigations, 73, 311.
19. Scotlandi K., Benini S., Sarti M., Serra M., Lollini PL., Maurici D., Picci P., Manara M.C., Baldini N. (1996) Insulin-like growth factor-2 receptor-mediated circuit in Ewing's sarcomas/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Research, 56, 4570.
20. Scotlandi K., Benini S., Nanni P., Lollini P.L., Nicoletti G., Landuzzi L., Serra M., Manara M.C., Picci P., Baldini M. (1998) Blockage of insulin-like growth factor-1 receptor inhibited growth of Ewing's sarcoma in athymic mice. Cancer Research, 58, 4127.
21. Sell S., Baserga R., Rubin R. (1995) Insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Research, 55, 303.
22. Shapiro D.N., Jones B.G., Shapiro L.H., Dias P., Houghton P.J. (1994) Antisense-mediated reduction of insulin-like growth factor-1 receptor expression suppresses the malignant phenotype of human alveolar rhabdomyosarcoma. Journal of Clinical Investigations, 94, 1235.
23. Triche T.J. (1990) Neuroblastoma and other childhood neural tumors: a review. Pediatric Pathology, 10, 75.
24. van der Ven L.T., van Buul-Offers S.C., Gloudemans T., Roholl P.J., Sussenbach J.S., den Otter W. (1997) Histamine-stimulated expression of insulin-like growth factors in human glioma cells. British Journal of Cancer, 75, 1091.
25. Warren R.S. Yuan, Matli M.R., Herrara M., Donner D.B. (1996) Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. Journal Biological Chemistry, 271, 29483.